RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsPfizer's market cap is US$ 232 Billion and the company's CEO has stated that Pfizer is looking at "smaller acquisitions" valued at below Pfizer's valuation. So there is plenty of opportunity foe ONCY to be acquired at Big Pharma's "sweet spot " or above, should Pfizer choose.